Kingsnorth AW, Galloway SW, Formela LJ: Randomized, double-blind phase II trial of Lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis.
Intracellular calcium measurements in rat PIEC following exposure to PAF (100 nmol/L).
2-lyso-PAF necessary for PAF synthesis via the remodeling pathway.